Raymond James Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$12.2M Sell
19,733
-93
-0.5% -$55.1K 0.27% 85
2024
Q2
$11M Sell
19,826
-157
-0.8% -$89.9K 0.26% 84
2024
Q1
$11.6M Buy
19,983
+277
+1% +$155K 0.28% 83
2023
Q4
$10.5M Buy
19,706
+382
+2% +$185K 0.28% 81
2023
Q3
$9.78M Buy
19,324
+3,295
+21% +$1.76M 0.29% 78
2023
Q2
$8.36M Buy
16,029
+14
+0.1% +$7.55K 0.24% 94
2023
Q1
$9.23M Buy
16,015
+238
+2% +$134K 0.29% 77
2022
Q4
$8.69M Sell
15,777
-265
-2% -$140K 0.29% 81
2022
Q3
$8.14M Buy
16,042
+893
+6% +$500K 0.3% 79
2022
Q2
$8.23M Buy
15,149
+1,009
+7% +$555K 0.29% 78
2022
Q1
$8.35M Sell
14,140
-130
-0.9% -$74.7K 0.26% 90
2021
Q4
$9.52M Sell
14,270
-469
-3% -$293K 0.28% 81
2021
Q3
$8.42M Buy
14,739
+467
+3% +$256K 0.28% 84
2021
Q2
$7.2M Sell
14,272
-236
-2% -$111K 0.24% 96
2021
Q1
$6.62M Buy
14,508
+359
+3% +$171K 0.23% 100
2020
Q4
$6.59M Buy
14,149
+278
+2% +$130K 0.25% 92
2020
Q3
$6.13M Buy
13,871
+137
+1% +$56.6K 0.26% 86
2020
Q2
$4.98M Buy
13,734
+120
+0.9% +$40.2K 0.24% 94
2020
Q1
$3.86M Buy
13,614
+1,559
+13% +$492K 0.23% 100
2019
Q4
$3.92M Sell
12,055
-427
-3% -$129K 0.19% 117
2019
Q3
$3.64M Buy
12,482
+1,140
+10% +$326K 0.19% 115
2019
Q2
$3.33M Sell
11,342
-60
-0.5% -$16.5K 0.18% 121
2019
Q1
$3.12M Buy
11,402
+20
+0.2% +$4.98K 0.18% 123
2018
Q4
$2.55M Sell
11,382
-385
-3% -$90.3K 0.16% 136
2018
Q3
$2.87M Buy
11,767
+127
+1% +$29.2K 0.16% 139
2018
Q2
$2.41M Buy
11,640
+962
+9% +$204K 0.15% 150
2018
Q1
$2.2M Sell
10,678
-204
-2% -$42.8K 0.15% 155
2017
Q4
$2.07M Sell
10,882
-85
-0.8% -$16.3K 0.14% 163
2017
Q3
$2.08M Buy
10,967
+83
+0.8% +$15K 0.15% 147
2017
Q2
$1.9M Buy
10,884
+144
+1% +$24.2K 0.14% 156
2017
Q1
$1.65M Sell
10,740
-427
-4% -$65.3K 0.13% 172
2016
Q4
$1.58M Buy
11,167
+5,209
+87% +$768K 0.13% 174
2016
Q3
$947K Buy
5,958
+129
+2% +$19.9K 0.08% 226
2016
Q2
$862K Sell
5,829
-1,004
-15% -$148K 0.08% 240
2016
Q1
$968K Sell
6,833
-640
-9% -$85.8K 0.09% 214
2015
Q4
$1.06M Buy
7,473
+318
+4% +$42.4K 0.1% 197
2015
Q3
$874K Sell
7,155
-1,207
-14% -$157K 0.1% 198
2015
Q2
$1.08M Buy
8,362
+115
+1% +$15K 0.12% 185
2015
Q1
$1.11M Sell
8,247
-83
-1% -$10.7K 0.12% 182
2014
Q4
$1.04M Sell
8,330
-228
-3% -$27.7K 0.11% 196
2014
Q3
$1.04M Sell
8,558
-583
-6% -$70.9K 0.12% 185
2014
Q2
$1.08M Buy
9,141
+1,098
+14% +$129K 0.12% 175
2014
Q1
$967K Buy
8,043
+1,121
+16% +$133K 0.12% 180
2013
Q4
$771K Sell
6,922
-654
-9% -$65K 0.1% 194
2013
Q3
$698K Sell
7,576
-703
-8% -$63.6K 0.11% 192
2013
Q2
$700K Buy
+8,279
New +$689K 0.11% 187

Other funds holding TMO

Raymond James Trust's TMO Position: Q3 2024 in Review

Raymond James Trust reduced its Thermo Fisher Scientific (TMO) stake by 0.47% in Q3 2024, selling an estimated $55.1K and leaving 19,733 shares worth $12.2M. The position accounts for 0.27% of the portfolio, ranked #85.

Raymond James Trust first reported a position in TMO in Q2 2013 and has held it in 46 quarters since. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Raymond James Trust held 19,733 shares of Thermo Fisher Scientific worth $12.2M as of Q3 2024.
  • Raymond James Trust sold 93 Thermo Fisher Scientific shares in Q3 2024, an estimated $55.1K.
  • Thermo Fisher Scientific made up 0.27% of Raymond James Trust's portfolio in Q3 2024, its #85 holding.
  • Raymond James Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 46 quarters since.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.